SEC Company Response from Coherus Oncology, Inc. (CHRS) (CIK 0001512762) (CHRS) — May 4, 2018
Coherus Oncology, Inc. (CHRS) (CIK 0001512762)
Date: May 4, 2018 · CIK: 0001512762 · Accession: 0001193125-18-152800
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222698
Letter
Company Acceleration Request
Coherus BioSciences, Inc.
333 Twin Dolphin Drive, Suite 600
Redwood City, CA 94065
May 4, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Chris Edwards
Re: Coherus BioSciences, Inc.
Registration Statement on Form S-3 (Registration No. 333-222698)
Initially Filed January 25, 2018 and Amended May 4, 2018
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration by the Securities and Exchange Commission of the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) of Coherus BioSciences, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on May 7, 2018, or as soon as practicable thereafter.
Thank you for your assistance in this matter.
Very truly yours,
Coherus BioSciences, Inc.
Show Raw Text
CORRESP 1 filename1.htm Company Acceleration Request Coherus BioSciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City, CA 94065 May 4, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Chris Edwards Re: Coherus BioSciences, Inc. Registration Statement on Form S-3 (Registration No. 333-222698) Initially Filed January 25, 2018 and Amended May 4, 2018 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration by the Securities and Exchange Commission of the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) of Coherus BioSciences, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on May 7, 2018, or as soon as practicable thereafter. Thank you for your assistance in this matter. Very truly yours, Coherus BioSciences, Inc. By: /s/ Jean-Frédéric Viret Jean-Frédéric Viret Chief Financial Officer